Drug recall
Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics…
FDA recall event 82496 · Class I · Aurobindo Pharma USA Inc.
Key facts
| Event ID | 82496 |
|---|---|
| Recall numbers | D-1248-2019 |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Product type | Drugs |
| Products | Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05 |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Presence of Particulate Matter: One vial was found to contain a hair. |
| Initiation date | Mar 28, 2019 |
| Report date | Apr 17, 2019 |
| Termination date | Apr 11, 2024 |
| City | East Windsor |
| State | NJ |
| Country | United States |
| FEI number | 3014213061 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: